375 results
Page 8 of 19
8-K
EX-99.1
1r9pif9fgu9n2kn7zni
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99.1
7f13jh8m8x6c
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.1
gte92kjl 31c
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.4
0r1r5 ythxji
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.3
b45jteowg4m5r0d cplj
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.5
3hlzh v6bx0r
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
i8l7ps 32xyo
9 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99
e1r0lih4
13 Mar 14
Other Events
12:00am
8-K
EX-99
6ob79zr
6 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
uwrgs59ievp9 ns
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
8-K
EX-99.1
cixo0pp 57c
8 Jan 14
Other Events
12:00am
8-K
EX-99.1
d6s7wa33set7ent
18 Dec 13
Other Events
12:00am
8-K
EX-99
kpmztc1s6ofzvvkga
6 Dec 13
Other Events
12:00am
8-K
EX-99
hb8ad iiy
30 Oct 13
Other Events
12:00am
8-K
EX-99
4ber uqz8l2uz2
20 Sep 13
Other Events
12:00am
8-K
EX-99
xheb 08ridxejlude
19 Sep 13
Regulation FD Disclosure
12:00am